DOPAL initiates αSynuclein-mediated impaired proteostasis in neuronal projections leading to enhanced vulnerability in Parkinson's disease.
Anna Masato, Nicoletta Plotegher, Andrea Thor, Stephen Adams, Michele Sandre, Susanna Cogo, Federica De Lazzari, Camilla Maria Fontana, Paul Anthony Martinez, Randy Strong, Arianna Bellucci, Marco Bisaglia, Elisa Greggio, Luisa Dalla Valle, Daniela Boassa, Luigi Bubacco
This study shows DOPAL promotes αSynuclein accumulation and impairs proteostasis in neuronal projections, contributing to Parkinson's disease progression.
bioRxiv · Jun 15, 2021 · PreprintNeuroscience